(Q44480310)

3 December 2017

title

Serum levels of osteoprotegerin increase with age in a healthy adult population (English)

1 reference

3 December 2017

S Kudlacek

1

1 reference

3 December 2017

B Schneider

2

1 reference

3 December 2017

W Woloszczuk

3

1 reference

3 December 2017

P Pietschmann

4

1 reference

3 December 2017

R Willvonseder

5

1 reference

3 December 2017

Austrian Study Group on Normative Values of Bone Metabolism

6

1 reference

3 December 2017

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

32

1 reference

3 December 2017

issue

6

1 reference

3 December 2017

page(s)

681-686

1 reference

Regulation of osteoclast activity

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Correlates of osteoprotegerin levels in women and men.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Osteoprotegerin: a link between osteoporosis and arterial calcification?

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Osteoporosis and coronary atherosclerosis in asymptomatic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Parathyroid hormone stimulates TRANCE and inhibits osteoprotegerin messenger ribonucleic acid expression in murine bone marrow cultures: correlation with osteoclast-like cell formation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2803%2900090-5

7 January 2021

10.1016/S8756-3282(03)00090-5

Identifiers

DOI

1 reference

3 December 2017

1 reference